Search

Your search keyword '"Freedman, Arnold"' showing total 667 results

Search Constraints

Start Over You searched for: Author "Freedman, Arnold" Remove constraint Author: "Freedman, Arnold"
667 results on '"Freedman, Arnold"'

Search Results

1. A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

2. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

3. Efficacy results of a phase 2 trial of first-line idelalisib plus ofatumumab in chronic lymphocytic leukemia

4. Rituximab/bendamustine and rituximab/cytarabine induction therapy for transplant-eligible mantle cell lymphoma

5. PD-1 blockade for diffuse large B-cell lymphoma after autologous stem cell transplantation

6. The Public Repository of Xenografts Enables Discovery and Randomized Phase II-like Trials in Mice

7. PD-1 blockade with pembrolizumab for classical Hodgkin lymphoma after autologous stem cell transplantation

8. A multi-cohort phase 1b trial of rituximab in combination with immunotherapy doublets in relapsed/refractory follicular lymphoma

10. Supplementary Table 6 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

11. Supplementary Methods, Figures 1-4 and Tables 1 - 5, 7 - 15 from Integrative Genomic Analysis Implicates Gain of PIK3CA at 3q26 and MYC at 8q24 in Chronic Lymphocytic Leukemia

12. Idelalisib given front-line for treatment of chronic lymphocytic leukemia causes frequent immune-mediated hepatotoxicity

13. Minimal residual disease in patients with diffuse large B-cell lymphoma undergoing autologous stem cell transplantation

14. Dual Immune Checkpoint Agents in Combination with Rituximab for Patients with Relapsed or Refractory Follicular Lymphoma

24. Prognostic Value of Minimal Residual Disease (MRD) Among Patients with Classical Hodgkin Lymphoma Undergoing Autologous Stem Cell Transplantation

28. Phase I Safety and Preliminary Efficacy of Acalabrutinib, Venetoclax, and Obinutuzumab (AVO) in Patients with Relapsed/Refractory Mantle Cell Lymphoma

31. Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma

34. Targeting constitutively active STAT3 in chronic lymphocytic leukemia: A clinical trial of the STAT3 inhibitor pyrimethamine with pharmacodynamic analyses

35. Detection of circulating tumour DNA in patients with aggressive B-cell non-Hodgkin lymphoma

43. A prospective study of minimal residual disease in patients with diffuse large B-cell lymphoma using an Ig-NGS assay

44. Interim Positron Emission Tomography (iPET) Assessed Using Deauville Score for Patients with Follicular Lymphoma Receiving First-Line Chemoimmunotherapy

45. Prognostic Value of Circulating Tumor DNA (ctDNA) in Autologous Stem Cell Graft and Post-Transplant Plasma Samples Among Patients with Diffuse Large B-Cell Lymphoma

49. A 60-year-old woman with epidural and paraspinal masses

50. Phase II study of a TLR-9 agonist (1018 ISS) with rituximab in patients with relapsed or refractory follicular lymphoma

Catalog

Books, media, physical & digital resources